Financial Advisors Network, Inc. Eli Lilly & CO Transaction History

Financial Advisors Network, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $203,874 - $281,071	469 New	469 $251,000
Q1 2019 Jun 04, 2019	SELL	$111.31 - $131.02 $392,812 - $462,369	-3,529 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $45,007 - $50,422	425 Added 13.69%	3,529 $408,000
Q2 2018 Aug 14, 2018	BUY	$75.7 - $86.88 $234,972 - $269,675	3,104 New	3,104 $265,000

4,267

757M

10.2M

11.4M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $837B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Financial Advisors Network, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Advisors Network, Inc. with notifications on news.